VanEck Pharmaceutical ETF (PPH)
- Previous Close
86.92 - Open
86.72 - Bid 86.16 x 200
- Ask 86.65 x 200
- Day's Range
86.07 - 86.72 - 52 Week Range
74.05 - 91.16 - Volume
79,897 - Avg. Volume
124,982 - Net Assets 543.21M
- NAV 86.89
- PE Ratio (TTM) 20.86
- Yield 1.87%
- YTD Daily Total Return 7.47%
- Beta (5Y Monthly) 0.60
- Expense Ratio (net) 0.36%
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
VanEck
Fund Family
Health
Fund Category
543.21M
Net Assets
2011-12-20
Inception Date
Performance Overview: PPH
Trailing returns as of 4/23/2024. Category is Health.
People Also Watch
Holdings: PPH
Top 10 Holdings (63.83% of Total Assets)
Sector Weightings
Recent News: PPH
Research Reports: PPH
Analyst Report: Elevance Health, Inc.
Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.
RatingPrice TargetRMBS: Lowering target price to $62.00
RAMBUS INC has an Investment Rating of HOLD; a target price of $62.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetRMBS: Raising target price to $65.00
RAMBUS INC has an Investment Rating of HOLD; a target price of $65.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetVRSN: Raising target price to $201.00
VERISIGN INC has an Investment Rating of HOLD; a target price of $201.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target